PROSTATIC ADENOMA (BENIGN PROSTATIC HYPERPLASIA)

Abstract

Benign prostatic hyperplasia (BPH), also known as prostatic adenoma, is one of the most prevalent urological conditions affecting aging men. It is characterized by nonmalignant enlargement of the prostate gland due to hyperplasia of stromal and epithelial components. This enlargement contributes to lower urinary tract symptoms (LUTS), significantly impairing quality of life. This review provides an in-depth analysis of epidemiology, pathophysiology, molecular mechanisms, clinical manifestations, diagnostic approaches, and modern management strategies, including pharmacological and surgical interventions.